Operating Company Healthcare

Novotech

Singapore, New South Wales, Singapore

Novotech is a full-service clinical research organization (CRO) and scientific advisory company providing clinical trial management, regulatory support, and related drug development services, with a global footprint spanning Asia-Pacific, North America, and Europe.

Focus Areas
Contract Research Organization (CRO), Clinical trial management, Regulatory affairs

Tracked deals

3

3 tracked deals across 2023-2026.

Recent pace

1

1 tracked deal announced in the last 12 months.

Deal mix

Buyout

3 buyout

Novotech Acquisition Volume by Year

Last 2 years

Acquisition volume by year Annual acquisition counts for the last 2 years for Novotech. 2 2023 ~1 est. 1 2026
Actual Full-year estimate

Supporting Data

Recent Transactions

  • Novotech to Acquire Agilex Biolabs from Healius to Expand Australian Bioanalytical Services
    September 25, 2026
    Buyer
    Novotech
    Target
    Agilex Biolabs
    Seller
    a wholly owned subsidiary of Healius (ASX: HLS)
    Industry
    Healthcare Services
    Location
    South Australia, Australia
    Type
    Buyout

    Novotech entered into an agreement to acquire Agilex Biolabs, an Adelaide-based Australian specialist bioanalytical laboratory business, from a wholly owned subsidiary of Healius. The deal is intended to expand Novotech’s laboratory capabilities in Australia and strengthen integrated clinical research and laboratory services for biotechnology and pharmaceutical clinical trial sponsors. Financial terms were not disclosed, and closing remains subject to customary regulatory conditions.

  • Novotech Acquires EastHORN Clinical Services
    January 10, 2023
    Buyer
    Novotech
    Target
    EastHORN Clinical Services
    Industry
    Healthcare Services
    Location
    Scotland, United Kingdom
    Type
    Buyout

    Novotech, the Asia-Pacific biotech specialist CRO, has acquired European contract research organization EastHORN Clinical Services to strengthen its global operations and European infrastructure. EastHORN — established in 2004 with more than 250 employees and operations across 30+ European countries — will retain its brand while being integrated into Novotech's systems to offer clients expanded in‑country expertise and access to Novotech's Asia‑Pacific and US capabilities.

  • Novotech Acquires US-based Regulatory Consulting Firm CBR International
    January 9, 2023
    Buyer
    Novotech
    Target
    CBR International
    Industry
    Healthcare Services
    Location
    Colorado, United States
    Type
    Buyout

    Novotech, an Asia-Pacific–focused clinical research organization (CRO), has acquired US-based regulatory and drug development consultancy CBR International. The acquisition strengthens Novotech's US FDA regulatory, scientific and clinical development capabilities to better support biotech and pharma clients across the US, Europe and Asia-Pacific.

Related Acquisition Pages

Healthcare Services Buyers & Acquisitions 3 tracked deals by Novotech. Acquisitions in Colorado 1 tracked deal by Novotech.

Related articles

Selling a company? Get in front of buyers like Novotech

Turn tracked acquisition activity into an outreach-ready buyer list.

Find buyers like these →